VALSECCHI, MARIA GRAZIA
 Distribuzione geografica
Continente #
NA - Nord America 53.641
AS - Asia 31.170
EU - Europa 24.807
SA - Sud America 4.699
AF - Africa 797
OC - Oceania 231
Continente sconosciuto - Info sul continente non disponibili 55
Totale 115.400
Nazione #
US - Stati Uniti d'America 52.271
SG - Singapore 11.161
CN - Cina 6.329
IT - Italia 5.424
VN - Vietnam 4.764
HK - Hong Kong 4.121
RU - Federazione Russa 3.702
DE - Germania 3.574
BR - Brasile 3.426
SE - Svezia 2.793
IE - Irlanda 2.300
UA - Ucraina 1.608
GB - Regno Unito 1.368
FR - Francia 1.085
IN - India 1.082
CA - Canada 894
FI - Finlandia 659
BD - Bangladesh 509
AT - Austria 475
KR - Corea 433
AR - Argentina 430
ID - Indonesia 400
TR - Turchia 392
NL - Olanda 356
IQ - Iraq 354
ES - Italia 302
MX - Messico 298
ZA - Sudafrica 249
JP - Giappone 247
PK - Pakistan 220
AU - Australia 212
SA - Arabia Saudita 207
DK - Danimarca 194
PL - Polonia 194
EC - Ecuador 188
CO - Colombia 181
PH - Filippine 166
BE - Belgio 152
VE - Venezuela 124
UZ - Uzbekistan 104
MA - Marocco 96
PE - Perù 94
PT - Portogallo 94
CH - Svizzera 92
CL - Cile 92
PY - Paraguay 91
EG - Egitto 89
CZ - Repubblica Ceca 69
KE - Kenya 68
JO - Giordania 67
MY - Malesia 62
LT - Lituania 53
ET - Etiopia 52
AE - Emirati Arabi Uniti 51
RO - Romania 51
TN - Tunisia 50
IR - Iran 47
NP - Nepal 46
DZ - Algeria 43
EU - Europa 40
TH - Thailandia 39
GR - Grecia 38
IL - Israele 37
AZ - Azerbaigian 36
UY - Uruguay 36
JM - Giamaica 34
TW - Taiwan 33
KZ - Kazakistan 32
AL - Albania 31
LB - Libano 31
OM - Oman 31
BO - Bolivia 30
MD - Moldavia 29
PS - Palestinian Territory 29
BG - Bulgaria 27
RS - Serbia 25
CR - Costa Rica 21
PA - Panama 21
SN - Senegal 20
GT - Guatemala 19
DO - Repubblica Dominicana 18
KG - Kirghizistan 18
LV - Lettonia 18
NZ - Nuova Zelanda 18
NG - Nigeria 17
NO - Norvegia 17
BH - Bahrain 16
CI - Costa d'Avorio 16
HU - Ungheria 16
NI - Nicaragua 16
SK - Slovacchia (Repubblica Slovacca) 14
AO - Angola 13
QA - Qatar 13
SC - Seychelles 13
BY - Bielorussia 12
BB - Barbados 11
HN - Honduras 11
SY - Repubblica araba siriana 11
TT - Trinidad e Tobago 10
GE - Georgia 9
Totale 115.181
Città #
Ann Arbor 8.108
Singapore 6.456
Ashburn 4.743
Hong Kong 4.025
Woodbridge 3.780
Fairfield 3.303
San Jose 2.846
Houston 2.506
Chandler 2.501
Frankfurt am Main 2.308
Dublin 2.221
Wilmington 1.765
Jacksonville 1.600
Ho Chi Minh City 1.410
Milan 1.386
New York 1.352
Seattle 1.297
Hanoi 1.156
Cambridge 1.149
Dearborn 1.046
Santa Clara 1.012
Beijing 920
Chicago 918
Los Angeles 896
Princeton 846
Dallas 794
The Dalles 735
Hefei 711
Nanjing 483
Lauterbourg 453
Shanghai 425
Altamura 403
Lawrence 397
Seoul 382
Vienna 364
Buffalo 328
Council Bluffs 324
Moscow 324
São Paulo 322
Jakarta 284
Lachine 269
Helsinki 254
Guangzhou 224
Rome 222
London 210
San Diego 207
Boardman 198
Orem 186
Munich 177
Melbourne 167
Nanchang 158
Toronto 158
Tokyo 151
Haiphong 145
Warsaw 145
Da Nang 140
Rio de Janeiro 137
Baghdad 136
Nuremberg 136
Andover 134
Montreal 132
Shenyang 129
Tianjin 127
Chennai 123
Johannesburg 120
Lissone 118
Ottawa 116
Dong Ket 113
Brooklyn 112
Changsha 110
Hebei 108
Salt Lake City 107
Brussels 104
Biên Hòa 97
Denver 97
Jinan 95
Dhaka 92
Tashkent 91
Boston 83
Columbus 83
Mumbai 83
Norwalk 82
Poplar 82
Bologna 79
Atlanta 78
Falls Church 78
Monza 77
Fremont 76
Jeddah 76
Mountain View 76
Amsterdam 75
Stockholm 75
Quận Bình Thạnh 74
Jiaxing 73
Manchester 73
San Francisco 73
Belo Horizonte 72
Ha Long 72
Paris 72
Lahore 69
Totale 73.505
Nome #
New concepts on the clinical course and stratification of compensated and decompensated cirrhosis 1.447
Clinical states of cirrhosis and competing risks 739
Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome 698
Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery 530
Four Additional Doses of PEG-L-Asparaginase during the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study 517
Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study 516
Enzymatic replacement therapy for Hunter disease: Up to 9 years experience with 17 patients 456
Study protocol: understanding the pathophysiologic mechanisms underlying delirium in older people undergoing hip fracture surgery 443
Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib 442
Nomograms to identify elevated blood pressure values and left ventricular hypertrophy in a paediatric population: American Academy of Pediatrics Clinical Practice vs. Fourth Report/European Society of Hypertension Guidelines 439
The SIPI for measuring complexity in nursing care: Evaluation study 438
Predictive value of minimal residual disease in philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies 436
Effects of antenatal indomethacin on ductus arteriosus early closure and on adverse outcomes in preterm neonates 432
IKZF1 plus defines a new minimal residual disease-dependent very-poor prognostic profile in pediatric b-cell precursor acute lymphoblastic leukemia 429
Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960–1999 and registered in the Italian Off-Therapy Registry 424
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 424
Clinical features and outcome of SIL/TAL1-positive t-cell acute lymphoblastic leukemia in children and adolescents: A 10-year experience of the AIEOP group 419
Imatinib Long-Term Effects Study: Global Independent Assessment of Imatinib in Chronic Myeloid Leukemia: Results At 8 Years 416
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System 416
Pulse wave velocity progression over a medium-term follow-up in hypertensives: Focus on uric acid 403
Pentraxin 3 plasma levels at graft-versus-host disease onset predict disease severity and response to therapy in children given haematopoietic stem cell transplantation 398
Adverse events in single-arm clinical trials with non-fatal time-to-event efficacy endpoint: from clinical questions to methods for statistical analysis 396
Noninvasive Ventilatory Support of COVID-19 Patients Outside the Intensive Care Units (WARd-COVID) 391
Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection 388
Remdesivir use in patients requiring mechanical ventilation due to COVID-19 388
Indicators of guideline-concordant care in lung cancer defined with a modified Delphi method and piloted in a cohort of over 5,800 cases 386
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia 386
The relationship between frailty and delirium: insights from the 2017 Delirium Day study 384
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 383
Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20) 380
Joint model robustness compared with the time-varying covariate Cox model to evaluate the association between a longitudinal marker and a time-to-event endpoint 380
ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells 375
Unravelling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis 373
Three-year National report from the Gruppo Italiano di Ortogeriatria (GIOG) in the management of hip-fractured patients 372
Multi-center randomized controlled trial on the effect of triclosan-coated sutures on surgical site infection after colorectal surgery 371
Basket trials in very rare diseases: are they feasible? 368
Carotid plaque echolucency increases the risk of stroke in carotid stenting: The imaging in carotid angioplasty and risk of stroke (ICAROS) study 365
Imatinib long term effects study: three years of follow-up and assessment 365
A new prognostic index of severity of intellectual disabilities in Cornelia de Lange syndrome 365
A second update on mapping the human genetic architecture of COVID-19 361
Validation of the Italian version of the full and abbreviated Trust in Oncologist Scale 361
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 361
Effectiveness of treatments for acute and sub-acute mechanical non-specific low back pain: Protocol for a systematic review and network meta-analysis 357
How do self-care maintenance, self-care monitoring, and self-care management affect glycated haemoglobin in adults with type 2 diabetes? A multicentre observational study 357
Effects of lifestyle modifications on elevated blood pressure and excess weight in a population of Italian children and adolescents 356
Complexity of nursing care at 24 h from admission predicts in-hospital mortality in medical units: A cohort study 354
Impact of Continuous vs Bolus Feeding on Splanchnic Perfusion in Very Low Birth Weight Infants: A Randomized Trial 353
The role of blood pressure, body weight and fat distribution on left ventricular mass, diastolic function and cardiac geometry in children 352
Modeling the hazard of transition into the absorbing state in the illness-death model 350
Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis 346
One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study 346
Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study 343
Validation of a skewed surrogate endpoint for a time-to-event outcome: the use of a Zaga distribution 342
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS) 337
Glutamine-enriched intravenous total parenteral nutrition doesn't improve mucositis and clinical outcome after stem cell transplantation for childhood malignancies. A prospective double- blind controlled study on behalf of AIEOP Group 336
NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL 336
BIVARIATE COPULA MODELS IN THE PRESENCE OF COMPLEX PATTERNS FOR THE SURROGATE ENDPOINT FOR A SURVIVAL TRUE ENDPOINT 335
Mapping the human genetic architecture of COVID-19 334
Reduced-Intensity delayed intensification in standard-Risk pediatric acute lymphoblastic leukemia defined by undetectable minimal residual disease: Results of an international randomized trial (AIEOP-BFM ALL 2000) 331
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis 329
Uric acid in chronic coronary syndromes: Relationship with coronary artery disease severity and left ventricular diastolic parameter 325
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 324
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings 321
The high volume of patients admitted during the SARS-CoV-2 pandemic has an independent harmful impact on in-hospital mortality from COVID-19 319
Molecular trait of follicular-patterned thyroid neoplasms defined by MALDI-imaging 318
Graphical representations and summary indicators to assess the performance of risk predictors 317
Body temperature at nursery admission in a cohort of healthy newborn infants: Results from an observational cross-sectional study 317
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort 316
Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler Syndrome 314
Endometrial cancer: correlation of apparent diffusion coefficient with tumor grade, depth of myometrial invasion, and presence of lymph node metastases 308
Association between uric acid and pulse wave velocity in hypertensive patients and in the general population: a systematic review and meta-analysis 307
Posterior fossa syndrome in a population of children and young adults with medulloblastoma: a retrospective, multicenter Italian study on incidence and pathophysiology in a histologically homogeneous and consecutive series of 136 patients 305
Maternal perception of excess weight in children: a survey conducted by paediatricians in the province of Milan 305
Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity 305
Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia 303
Autologous Purified Peripheral Blood Stem Cell Transplantation Compare to Chemotherapy in Childhood Acute Lymphoblastic Leukemia after Low-Risk Relapse 303
Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection 302
Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study 302
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin 301
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 300
CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemia 300
Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nerve 300
High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic Leukemia 299
Usefulness of waist circumference for the identification of childhood hypertension 299
Sudden death and associated factors in a historical cohort of chronic haemodialysis patients 298
Increased serum uric acid levels blunt the antihypertensive efficacy of lifestyle modifications in children at cardiovascular risk 298
HCC persistence or recurrence after bridging therapy helps predict transplant list dropout and generate a more equitable exception policy 296
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 296
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 296
Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants 296
Myometrial invasion in endometrial cancer: diagnostic performance of diffusion-weighted MR imaging at 1.5-T 294
The treatment of childhood acute lymphoblastic leukemia in Guatemala: Biologic features, treatment hurdles, and results 294
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia 293
MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: A randomised controlled trial protocol 292
Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: High white blood cell count at diagnosis is the strongest prognostic factor 291
Atrial fibrillation and low vitamin D levels are associated with severe vascular calcifications in hemodialysis patients 290
Modelling the hazard of transition into the absorbing state in the illness-death model 290
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 289
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 289
Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization 287
Totale 37.054
Categoria #
all - tutte 375.650
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 375.650


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.391 0 0 0 0 0 0 0 0 0 0 616 775
2021/20226.287 477 642 716 586 427 468 335 313 373 432 527 991
2022/202310.939 1.185 3.076 925 1.011 813 1.669 157 623 737 117 381 245
2023/20247.673 269 266 396 480 990 1.856 1.415 251 583 210 151 806
2024/202518.405 1.125 2.061 1.248 932 1.549 798 1.101 705 1.911 2.508 1.619 2.848
2025/202640.474 5.645 2.922 3.211 4.491 5.175 2.331 6.398 2.289 3.545 3.859 608 0
Totale 117.691